Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
Inventors
Taub, Marc Barry • Bugler, Jolyon Robert • Peyser, Thomas A.
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Publication Number
US-12458256-B2
Publication Date
2025-11-04
Expiration Date
Abstract
Methods and Devices to monitor the level of at least one analyte are provided.
Core Innovation
The invention provides a software-executed analyte monitoring system in which wireless communication is established between a receiver device and a data processing unit connected to a glucose sensor in contact with a bodily fluid under a skin surface of a user. The data processing unit senses glucose levels and generates a signal based on the sensed glucose levels, and after the wireless communication channel is established, the receiver device periodically receives the signal over a period of time.
The invention further integrates a wristwatch having a display and a user input device, where the wristwatch includes a resting state and an active state. In the active state, the wristwatch provides at least a first display mode and a second display mode, and through the user input device a selection between the display modes is received.
The first display mode is configured to display a current glucose level based on the received signal and the second display mode is configured to display a graph of the glucose level over the period of time. In response to a determination that the wristwatch is in the active state, the invention displays at least one of the current glucose level and the graph on the display in the selected display mode.
Claims Coverage
Two independent methods are identified, one centered on a receiver device executing software and one centered on the wristwatch executing software. The shared inventive theme is wireless reception of glucose-sensor-derived signals over time and user-selectable display modes that present either a current glucose level or a graph when the wristwatch is in an active state. Dependent claims further add communication-channel details, alarm modalities, and display indicators.
Wireless communication channel with glucose-sensing data processing unit
Establishing a wireless communication channel between a receiver device and a data processing unit connected to a glucose sensor in contact with a bodily fluid under a skin surface of a user, and periodically receiving over a period of time a signal generated based on sensed glucose levels.
Wristwatch user-selected display modes for current level or graph
A wristwatch with a display and a user input device, a resting state and an active state, and at least a first display mode and a second display mode, in which the user selects between displaying a current glucose level and displaying a graph of the glucose level over the period of time.
Software on the wristwatch establishes the wireless channel
Establishing a wireless communication channel using software executed on a wristwatch with a data processing unit connected to a glucose sensor, and periodically receiving over a period of time a signal generated based on sensed glucose levels.
Active-state display selection between current glucose level and graph
In response to a determination that the wristwatch is in the active state, displaying at least one of the current glucose level and the graph of the glucose level on the display in the selected display mode.
The independent claims define wireless reception of glucose-sensor-derived signals over time and user selection of first and second display modes on a wristwatch. When the wristwatch is in the active state, it displays at least one of the current glucose level and the graph in the selected mode. Dependent claims further specify Bluetooth-enabled communication, channel establishment using a unique identifier of the data processing unit, optional auditory, vibratory, or visual alarm modalities, and display indicators including arrow direction of change and indicators for hypoglycemia and hyperglycemia.
Stated Advantages
Not explicitly described in patent.
Documented Applications
Not explicitly described in patent.
Interested in licensing this patent?